Chronic Pancreatitis Overview
20 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Which statement about chronic pancreatitis (CP) is accurate?

  • CP is reversible with proper dietary changes.
  • CP primarily causes acute episodes of abdominal pain.
  • CP is defined solely based on genetic factors.
  • CP leads to both exocrine and endocrine dysfunction. (correct)
  • What is the incidence rate range for chronic pancreatitis in the population?

  • 10-15 cases per 100,000 population.
  • 1-5 cases per 100,000 population.
  • 3-9 cases per 100,000 population. (correct)
  • 15-20 cases per 100,000 population.
  • Which complication is associated with chronic pancreatitis?

  • Diabetes mellitus due to insulin cell damage. (correct)
  • Cirrhois.
  • Pancreatic adenoma.
  • Hepatic failure.
  • What is the role of EUS in the diagnosis of chronic pancreatitis?

    <p>It provides high-resolution imaging for early-stage diagnosis.</p> Signup and view all the answers

    Identify the mechanism through which pancreatic enzyme supplements function in chronic pancreatitis management.

    <p>They help digest fats, proteins, and carbohydrates.</p> Signup and view all the answers

    Which of the following best describes the nature of pain associated with chronic pancreatitis?

    <p>Nocturnal and potentially relieved by leaning forward.</p> Signup and view all the answers

    What is true about pancreatic cancer's incidence and characteristics?

    <p>Only 20% of cases are operable for cure.</p> Signup and view all the answers

    Which tumor type accounts for the majority of pancreatic cancer cases?

    <p>Pancreatic ductal adenocarcinoma (PDAC).</p> Signup and view all the answers

    What is a key risk factor for cholangiocarcinoma?

    <p>Chronic inflammatory conditions.</p> Signup and view all the answers

    What is a significant aspect of cholangiocarcinoma diagnosis?

    <p>Elevation of bilirubin and alkaline phosphatase often occurs.</p> Signup and view all the answers

    What is the most common presenting symptom of ampullary carcinoma?

    <p>Obstructive jaundice</p> Signup and view all the answers

    Which imaging technique is the most useful for identifying ampullary carcinoma and performing a biopsy?

    <p>ERCP</p> Signup and view all the answers

    In the treatment of intrahepatic CCA, which surgical procedure is typically performed?

    <p>Hepatic segmentectomy or lobectomy</p> Signup and view all the answers

    What factor primarily determines the prognosis of resected ampullary cancer in the absence of metastases?

    <p>Degree of local tumor invasion</p> Signup and view all the answers

    Which biochemical marker is widely used for detecting cholangiocarcinoma (CCA) in patients with primary sclerosing cholangitis (PSC)?

    <p>CA 19-9</p> Signup and view all the answers

    What complication might large ampullary carcinomas cause due to their location?

    <p>Gastric outlet obstruction</p> Signup and view all the answers

    What is the role of alkaline phosphatase in diagnosing ampullary carcinoma?

    <p>Reflects the presence of cholestasis</p> Signup and view all the answers

    Which age range represents the average age at diagnosis for ampullary carcinoma?

    <p>60 to 70 years</p> Signup and view all the answers

    What is the primary goal of palliative treatment for patients with ampullary carcinoma?

    <p>Reduce pain and jaundice</p> Signup and view all the answers

    Why is EUS typically not required for the diagnosis of ampullary carcinoma?

    <p>ERCP is more effective for diagnosis</p> Signup and view all the answers

    Study Notes

    Chronic Pancreatitis

    • Definition: A condition where the pancreas is chronically inflamed, leading to irreversible exocrine and endocrine dysfunction. More recently, it's defined as a pathologic fibroinflammatory syndrome in individuals with genetic, environmental or other risk factors leading to persistent pathologic responses to injury or stress.

    • Pancreas Anatomy: A soft, elongated, flattened gland, 12-20 cm long, situated in the epigastric and left hypochondriac regions of the abdominal cavity.

    • Pancreatic Functions:

      • Endocrine: Islet of Langerhans with alpha cells (glucagon, 20%), beta cells (insulin, 75%), and delta cells (somatostatin).
      • Exocrine: Pancreatic juice with enzymes (amylase, lipase, trypsin, chymotrypsin, carboxypeptidase) for digestion.
    • Digestion:

      • Digestion of protein: Trypsinogen and chymotrypsinogen are inactive enzyme precursors activated by enterokinase to trypsin and chymotrypsin which convert polypeptides to tripeptides and dipeptides.
      • Digestion of carbohydrates: Amylase converts polysaccharides to disaccharides.
      • Digestion of fats: Lipase converts fats to fatty acids.
    • Epidemiology:

      • Incidence: Ranges from 3-9 cases per 100,000 population per year in retrospective studies. A prospective study on alcoholic CP showed an incidence of 8.2 cases per 100,000 and an overall prevalence of 35.5 cases per 100,000.
      • Male to Female Ratio: 3.5:1 (based on a Japanese survey).
      • Survival: 10-year survival is roughly 70% and 20-year survival about 45%.
    • Socio-economic Effects:

      • Career: One-third of chronic pancreatitis patients cannot pursue their professional careers.
      • Employment: The rate of people losing employment is high (40%) and is related to prolonged illness or continued alcohol consumption.
      • Disability: Disability rates are significant (40%).
    • Etiology (TIGAR-O): Toxic and metabolic (alcohol, smoking, hypercalcemia, renal failure), idiopathic, genetic (CFTR, SPINK-1), autoimmune, recurrent and severe acute pancreatitis, obstructive (e.g. gallstones). Associated issues include oxidative stress, and toxic metabolic and necrosis-fibrosis, SAPE (severe acute pancreatitis with early complications) hypothesis, and large duct issues.

    • Alcohol as a risk factor: A period of >80g of alcohol per day for 6–12 years increases the risk of developing chronic pancreatitis. The type of alcohol consumed does not influence the risk. There is a delay of ~18 years between starting heavy alcohol consumption and the development of pancreatitis.

    • Clinical Manifestations:

      • Pain: Recurrent, severe, uncontrollable upper abdominal pain, radiating to the back, often worsening after meals.
      • Exocrine insufficiency: Diarrhea/steatorrhea (loss of exocrine function)
      • Endocrine insufficiency: Diabetes mellitus (loss of endocrine function).
    • Additional details on abdominal pain: no specific pattern, epigastric pain, radiating to the back, associated with nausea/vomiting, pain worsens postprandially, nocturnal, relieved by sitting forward or knee-chest position

    • Exocrine insufficiency details: steatorrhea does not occur until pancreatic lipase secretion is reduced to less than 10%, a feature of far-advanced CP, maldigestion of fats, proteins, and carbohydrates, and bulky, foul-smelling stools are common.

    • Endocrine insufficiency details: half of patients with CP who develop DM will require insulin, DM complications are common in patients with CP who have diabetes similar duration to type 1 DM patients, development of DM is most likely related to disease duration.

    • Diagnosis:

      • Functional tests (measure specific pancreatic functions)
      • Imaging (e.g., CT, MRI, ERCP)
      • Laboratory studies (e.g., serum amylase, lipase, CBC, electrolytes, LFTs)
    • Imaging role of ERCP - was historically gold standard for diagnosis of CP. Indications include patients for whom CT or MRCP is contraindicated/failed to corroborate the diagnosis. Also a therapeutic modality addressing strictures, stones, pseudocysts and biliary stenosis.

    • Imaging EUS- technique used to diagnose early stage CP. Rosemon criteria define diagnostic criteria.

    • Diagnostic algorithms: there are algorithms to follow for diagnosing CP.

    • Complications • Pseudocysts: Fluid and debris may collect, possibly rupturing and causing infection/bleeding. Jaundice may be common if the pseudocyst is in specific location in the pancreas. • Pancreatic abscess: Collection of pus in the pancreas. • Diabetes: Damage to insulin-producing cells. • Pancreatic ascites: Leakage of pancreatic juice from pseudocyst. • Pancreatic fistula: Occurs due to operative or percutaneous drainage of pseudocysts. • Malnutrition: Due to impaired absorption. • Splenic vein thrombosis: Result of peripancreatic inflammation.

    • Treatment:

      • Medical (pain management, enzyme supplementation, etc.)
      • Endoscopic approaches (e.g., stenting, sphincterotomy)
      • Surgical treatments (e.g., resection, drainage)

    Pancreatic Cancer

    • Introduction: Carcinoma of the exocrine pancreas, over 90% of pancreatic tumors, and a significant oncologic challenge. It is a biologically aggressive cancer from the onset. Only about 20% of cases are operable for cure. Survival is ~10–15% at 12 months after diagnosis.

    • Epidemiology: Varying global incidence, highest in Northeast Thailand.

    • Risk Factors:

      • Cigarette smoking.
      • Obesity
      • Chronic pancreatitis.
      • Hereditary pancreatitis.
      • Inherited cancer syndromes (hereditary breast/ovarian, familial atypical multiple mole melanoma, Peutz-Jeghers, Lynch syndrome, ataxia-telangiectasia, Li-Fraumeni).
      • Family history of pancreatic cancer (especially multiple family members, first-degree relatives/younger relatives <50 years old).
    • Clinical Presentation:

      • Commonly a "silent disease" in early stages with no symptoms. When symptomatic:
      • Weight loss.
      • Anorexia.
      • Nausea and vomiting.
      • Abdominal pain.
      • Obstructive jaundice characterized by “painless jaundice”, (head lesions).
      • New onset or worsening pre-existing diabetes.
    • Diagnostic Investigations:

      • Blood tests.
        • ESR (often elevated).
        • LFTs (may or may not be abnormal).
        • Tumor markers like CA19-9 (sensitivity/specificity varies, not typically diagnostic alone). CEA.
      • Imaging tests.
        • CT scan (primary modality).
        • MRI (useful for inconclusive CT, detecting small liver metastases).
        • EUS: often preferred if surgical resection may be an option.
        • ERCP, PTC (useful in cases with or for evaluation of biliary obstruction.
    • Classifications: TNM staging

    • Pathology: 95% arise in exocrine cells. Most common is pancreatic ductal adenocarcinoma (PDAC), accounting for ~80% of pancreatic cancers. Other variants exist (adenocarcinoma, undifferentiated with giant cell, acinar cell, pancreatic neuroendocrine tumors, cystic neoplasms, including IPMN and mucinous cystic neoplasms)

    • Treatment:

      • Surgical resection (resection is only possible for approximately 20% of patients due to factors such as metastases, advanced invasion, advanced cachexia). Surgery often involves:
        • Whipple procedure (standard approach).
        • Ampullectomy (reasonable approach for poor candidates)
      • Nonsurgical treatments (endoscopic, laser ablation, photodynamic therapy) are palliative, not curative.
      • Adjuvant chemotherapy: infusional 5-FU, gemcitabine and cisplatin are common options.

    Cholangiocarcinoma

    • Introduction: Cancer of the bile ducts arises from the epithelial cells of the biliary tree in intrahepatic, perihilar, or distal sections. A special type involving the hepatic duct bifurcation is called Klatskin.

    • Epidemiology: Highly variable based on location. Northeast Thailand has the highest rates of cases.

    • Risk factors: Several factors linked to CCA development:

      • Chronic pancreatitis.
      • PSC (primary sclerosing cholangitis).
      • Liver fluke infestations (e.g., Opisthorchis viverrini, Clonorchis sinensis).
      • Choledochal cysts.
      • Biliary cysts.
      • Biliary papillomatosis.
    • Clinical Presentation:

      • Painless jaundice (most prominent symptom, occurs when the tumor obstructs the bile ducts)
      • Pruritus (itching).
      • Abdominal pain
      • Weight loss
      • Fever (less common but may be present).
      • Cholangitis (inflammation of the bile ducts).
    • Diagnosis:

      • Laboratory tests: Elevated TBIL (total bilirubin), DBIL (direct bilirubin), ALK phosphatase are common. Also, AST, ALT, CA19-9, and CEA.
      • Imaging:
        • CT scan (identifies level of obstruction, tumors)
        • MRI/MRCP (further investigation if CT is inconclusive)
        • ERCP/PTC (useful for diagnostic/therapeutic procedures to assess or treat biliary obstruction)
        • Imaging reports should detail tumor characteristics, tumor-to-vessel contact for each peripancreatic vessel, locoregional involvement and presence of distant metastases
    • Treatment: Surgical approach varies based on tumor location:

      • Intrahepatic CCA: hepatic segmentectomy or lobectomy
      • Distal extrahepatic CCA: pancreatoduodenectomy
      • Hilar CCA: biliary duct resection and/or hepatic lobectomy
    • Other treatments:

      • Palliation (treatments addressing pain, jaundice): ERCP, percutaneous stenting

    Ampullary Carcinoma

    • Definition: Typically arises in the ampulla of Vater, where the common bile duct and the pancreatic duct join.
    • Epidemiology: Typically affects people 60-70 years of age. Sporadic/may be part of a genetic syndrome.
    • Clinical Presentation:
      • Obstructive jaundice
      • Diarrhea (fat malabsorption)
      • Mild weight loss and fatigue.
      • Occult GI bleeding.
      • Possible gastric outlet obstruction (severe nausea/vomiting)
    • Diagnosis and Staging:
      • Liver biochemical tests (can't definitively establish diagnosis, may reflect the presence of cholestasis).
      • Aminotransferases may be elevated. -CA19-9 and CEA
      • Imaging:
        • Abdominal US (first test for obstructive jaundice).
        • CT/MRI (to visualize the tumor).
        • ERCP (important for visualization, biopsy if need be).
        • EUS (not routinely needed for diagnosis) –
    • Prognosis and Treatment:
      • Surgical treatment remains the only potentially curative approach. Standard approach often involves pancreaticoduodenectomy (Whipple procedure). Option of ampullectomy may be considered for poor candidates.
      • Often palliative therapies address or manage complications. Includes adjuvant chemotherapy (infusional FU, gemcitabine, cisplatin) for resection candidates.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Description

    Explore the condition of chronic pancreatitis, including its definition, anatomical structure, and both endocrine and exocrine functions. This quiz will cover crucial aspects of pancreatic digestion and the impact of chronic inflammation. Test your knowledge on this significant health topic.

    More Like This

    C2: CHIRURGIA - pancreatite cronica (1)
    11 questions
    Chronic Pancreatitis
    156 questions

    Chronic Pancreatitis

    ExaltingTriumph4095 avatar
    ExaltingTriumph4095
    33 Pancreas ANATOMY AND PHYSIOLOGY
    55 questions
    Chronic Pancreatitis Overview
    63 questions

    Chronic Pancreatitis Overview

    ProficientOklahomaCity avatar
    ProficientOklahomaCity
    Use Quizgecko on...
    Browser
    Browser